Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced Biliary Tract Cancer
NCT04656249Phase 2Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in biliary tract cancer (BTC), sponsored by Peking Union Medical College Hospital. Started Jan 2018; status: completed.
02
Drugs
lenvatinib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04656249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656249.